Cargando…

The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant

The post-transplant scoring system (PTSS), developed by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy, is based on three independent post-transplant risk factors: grade of acute graft-versus-host disease, lack of platelet recovery before day 100, and relapse before day...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alarcon Tomas, Ana, Whiting, Karissa, Maloy, Molly, Ruiz, Josel D., Devlin, Sean, Sanchez-Escamilla, Miriam, Yañez, Lucrecia, Castillo, Nerea, Pennisi, Martina, Cho, Christina, Shaffer, Brian, Castro-Malaspina, Hugo, Klimek, Virginia, Giralt, Sergio A., Tamari, Roni, Perales, Miguel-Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273566/ https://www.ncbi.nlm.nih.gov/pubmed/34253878 http://dx.doi.org/10.1038/s41409-021-01392-w

Ejemplares similares

Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
por: Nawas, Mariam T., et al.
Publicado: (2022)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
por: Fingrut, Warren B., et al.
Publicado: (2022)

Long-term prognosis for 1-year relapse-free survivors of CD34 cell–selected allogeneic hematopoietic stem cell transplantation: a landmark analysis
por: Cho, Christina, et al.
Publicado: (2017)

Low dose Unfractionated Heparin Prophylaxis is a Safe Strategy for the Prevention of Hepatic Sinusoidal Obstruction Syndrome After Myeloablative Adult Allogenic Stem Cell Transplant
por: Sola, Maria, et al.
Publicado: (2022)

Engraftment Kinetics after Transplantation of Double Unit Cord Blood Grafts Combined with Haplo-identical CD34+ Cells without Anti-thymocyte Globulin
por: Politikos, Ioannis, et al.
Publicado: (2020)

How I treat adverse effects of CAR-T cell therapy
por: Yáñez, Lucrecia, et al.
Publicado: (2020)

Voorkom burn-out en PTSS
por: Kiers, Bart
Publicado: (2020)

Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era
por: Mussetti, Alberto, et al.
Publicado: (2015)

Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review
por: Elko, Theresa A., et al.
Publicado: (2023)

2735. Treatment patterns and clinical outcomes of acyclovir resistant and refractory human herpes simplex virus infection after allogeneic hematopoietic cell transplantation
por: Lee, Yeon Joo, et al.
Publicado: (2023)

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT
por: Shouval, Roni, et al.
Publicado: (2022)

CAR T Cell Toxicity: Current Management and Future Directions
por: Yáñez, Lucrecia, et al.
Publicado: (2019)

SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS
por: Luger, Selina M., et al.
Publicado: (2011)

Hematopoietic Cell Transplantation for Older Patients with MDS
por: Shadman, Mazyar, et al.
Publicado: (2014)

Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
por: Yang, Guancui, et al.
Publicado: (2022)

Long Term Renal Survival in Patients undergoing T-Cell Depleted vs Conventional Hematopoietic Stem Cell Transplants
por: Glezerman, Ilya G., et al.
Publicado: (2017)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
por: Malard, Florent, et al.
Publicado: (2018)

1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience
por: Zavras, Phaedon D, et al.
Publicado: (2019)

Psychometric Properties of the Positive Thinking Skills Scale (PTSS) among Portuguese Adults
por: Almeida, Telma Catarina, et al.
Publicado: (2023)

Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
por: Scordo, Michael, et al.
Publicado: (2022)

Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
por: Tamari, Roni, et al.
Publicado: (2023)

Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy
por: Infante, Maria Stefania, et al.
Publicado: (2022)

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS
por: Chevallier, Patrice, et al.
Publicado: (2016)

Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation
por: Niscola, Pasquale, et al.
Publicado: (2019)

Lymph node tuberculosis after allogeneic haematopoietic stem cell transplantation: an atypical presentation of an uncommon complication
por: Martín-Sánchez, Guillermo, et al.
Publicado: (2015)

How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer
por: O'Connor, M, et al.
Publicado: (2011)

PB2060: THE MDS-SPECIFIC COMORBIDITY INDEX (MDS-CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION.
por: Koster, K.-L., et al.
Publicado: (2022)

Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
por: Yahng, Seung-Ah, et al.
Publicado: (2016)

Media Exposure Related to the PTSS During COVID-19 Pandemic: The Mediating Role of Risk Perception
por: Wang, Yiqing, et al.
Publicado: (2021)

Emotion Regulation Strategies Predict PTSS During the COVID-19 Pandemic in an American Indian Population
por: Tyra, Alexandra T., et al.
Publicado: (2021)

Predicting PTSS in general population during COVID-19 pandemic: The mediating role of health anxiety
por: Coloma-Carmona, Ainhoa, et al.
Publicado: (2021)

PTSS in COVID-19 survivors peritraumatic stress symptoms among COVID-19 survivors in Iraq
por: Mohammad, Parzheen J., et al.
Publicado: (2023)

1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karantoni, Eleni, et al.
Publicado: (2020)

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS
por: Michel, Claire, et al.
Publicado: (2023)

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
por: Pourhassan, H, et al.
Publicado: (2016)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
por: Prockop, Susan E., et al.
Publicado: (2023)

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT
por: Cremers, E. M. P., et al.
Publicado: (2016)

P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
por: Savic, Aleksandar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ug2l4v8ukbnm6oqmp0puu41afb